The reason why the BCAA group
should have continued to improve after
the end of treatment is not clear. It is possible that an adjunctive effect of the drink
for 1 week allowed a more rapid resolution
of the manic syndrome even after BCAA
treatment ended. In contrast, the placebo
improvement seemed to wane as would be
expected.